Using New Technologies to Treat Macular Degeneration

The Autumn 2021 edition of MacularNEWS looks at how the Macula Research Group is using the same technology that created the COVID-19 vaccine – messenger ribonucleic acid or mRNA – to find new and hopefully better ways of treating retinal diseases, including macular degeneration.

To read the latest edition of MacularNEWS please click here.